CN203616315U - Combined detecting card for coronary heart disease risk assessment - Google Patents
Combined detecting card for coronary heart disease risk assessment Download PDFInfo
- Publication number
- CN203616315U CN203616315U CN201320787802.2U CN201320787802U CN203616315U CN 203616315 U CN203616315 U CN 203616315U CN 201320787802 U CN201320787802 U CN 201320787802U CN 203616315 U CN203616315 U CN 203616315U
- Authority
- CN
- China
- Prior art keywords
- test
- strips
- crp
- lateral chromatography
- mpo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The utility model discloses a combined detecting card for the coronary heart disease risk assessment, and relates to the technical field of medical detection projects. An MPO (myeloperoxidase) lateral chromatography testing bar and a clamping slot thereof, as well as an hs-CRP (high-sensitivity C-reactive protein) lateral chromatography testing bar and a clamping slot thereof are arranged on a back plate of the detecting card; an upper cover is arranged above the back plate of the detecting card; display windows and sample adding holes are arranged at the positions, respectively corresponding to the clamping slot of the MPO lateral chromatography testing bar and the clamping slot of the hs-CRP lateral chromatography testing bar, on the upper cover. The combined detecting card can be used for synchronously carrying out the detection on an MPO project and an hs-CRP project, so as to help doctors to evaluate and diagnose the onset risk and exacerbation risk of patients suffering from the coronary heart disease quickly and conveniently.
Description
Technical field
The utility model relates to medical test item technical field, be specifically related to a kind of coronary heart disease risk assessment combination test card.
Background technology
The test card of lateral chromatography and golden mark technology is by detecting the body fluid compositions such as blood samples of patients, urine, to carry out the medical test consumptive material of immunoassay to human body.
In prior art, existing each producer test card is all individual event order single deck tape-recorder (install a test-strips in a test card and carry out a project detection) conventionally, while detection, can only detect item by item in the face of patient's entry simultaneously.Waste time and energy on the one hand, also caused on the one hand the waste of consumptive material shell.Also there is part producer that disparity items is carried out in same test-strips in same test card, but because the interference of different antibodies formula and test-strips fluid unstable caused the inaccurate of testing result.
In diagnosis and checking process for patients with coronary artery disease, doctor will carry out risk profile and assessment to the risk of coronary artery disease aggravation and generation heart stalk at present.A large amount of clinical literatures thinks that myeloperoxidase (MPO) detects index and has close relationship for the stability of coronary artery sclerosis patient's atheromatous plaque at present, is the important risk assessment index of patients with coronary heart disease generation acute myocardial infarction; A large amount of clinical literatures thinks that hs-CRP (hs-CRP) is also the important predictor of incidence of coronary heart disease risk simultaneously.These two projects combo inspections have great importance for the risk indagation of patients with coronary heart disease.Clinical practice test card or test strips all will detect when these two projects are detected conventionally item by item, adopt two test card just can complete.Complex operation, the waste of laboratory consumables and the rising of hospital costs when troublesome poeration, are also caused.
Utility model content
For the deficiency existing in prior art, the utility model object is to be to provide a kind of coronary heart disease risk assessment combination test card, carry out the detection of two projects of myeloperoxidase (MPO)/hs-CRP (hs-CRP), to help doctor realize fast, easily the onset risk of patients with coronary heart disease and increase the weight of risk and assess diagnosis and treatment simultaneously.
To achieve these goals, the utility model is to realize by the following technical solutions: a kind of coronary heart disease risk assessment combination test card, comprise test card backboard, upper cover, myeloperoxidase (MPO) lateral chromatography test-strips and draw-in groove, hs-CRP (hs-CRP) lateral chromatography test-strips and draw-in groove, display window and well, on test card backboard, be provided with myeloperoxidase (MPO) lateral chromatography test-strips draw-in groove, hs-CRP (hs-CRP) lateral chromatography test-strips draw-in groove, upper cover is arranged on test card backboard top, on cover corresponding to myeloperoxidase (MPO) lateral chromatography test-strips draw-in groove, the position of hs-CRP (hs-CRP) lateral chromatography test-strips draw-in groove is provided with display window and well.
In described myeloperoxidase (MPO) lateral chromatography test-strips draw-in groove, hs-CRP (hs-CRP) lateral chromatography test-strips draw-in groove, be respectively arranged with myeloperoxidase (MPO) lateral chromatography test-strips, hs-CRP (hs-CRP) lateral chromatography test-strips.
Described myeloperoxidase (MPO) lateral chromatography test-strips draw-in groove, hs-CRP (hs-CRP) lateral chromatography test-strips draw-in groove be arranged in parallel.Two test-strips are independent test bar; Test-strips puts in order and does not limit.
Described myeloperoxidase (MPO) lateral chromatography test-strips and hs-CRP (hs-CRP) lateral chromatography test-strips have respectively corresponding independent well and display window; And there is a project label of corresponding test-strips in upper cover shell corresponding position.
Described test card is rectangle.
The utlity model has following beneficial effect:
1, can carry out risk assessment effectively and indagation by projects combo to patients with coronary heart disease;
2, prevent that by projects combo doctor from omitting Interventions Requested;
3, combination project operation is more simple and convenient, and naked eyes interpretation or instrument interpretation are all more convenient efficient than traditional single deck tape-recorder individual event
The use of 4, having saved test card housing, reduces production costs.
5, test-strips region is independent, in lateral chromatography process between project without any impact, more than what realize entry in same test-strips detection accuracy will be good simultaneously.
6 test-strips regions are independent, and project label is clearer, are not easy erroneous judgement occurs and obscure.
Accompanying drawing explanation
Describe the utility model in detail below in conjunction with the drawings and specific embodiments;
Fig. 1 is the structural representation of test card upper cover of the present utility model;
Fig. 2 is the structural representation of test card backboard of the present utility model.
Embodiment
For technological means, creation characteristic that the utility model is realized, reach object and effect is easy to understand, below in conjunction with embodiment, further set forth the utility model.
With reference to Fig. 1-2, this embodiment is by the following technical solutions: a kind of coronary heart disease risk assessment combination test card, comprise test card backboard 1, upper cover 2, myeloperoxidase (MPO) lateral chromatography test-strips and draw-in groove 3, hs-CRP (hs-CRP) lateral chromatography test-strips and draw-in groove 4, display window 5 and well 6, on test card backboard 1, be provided with myeloperoxidase (MPO) lateral chromatography test-strips draw-in groove 3, hs-CRP (hs-CRP) lateral chromatography test-strips draw-in groove 4, upper cover 2 is arranged on test card backboard 1 top, on upper cover 2 corresponding to myeloperoxidase (MPO) lateral chromatography test-strips draw-in groove 3, the position of hs-CRP (hs-CRP) lateral chromatography test-strips draw-in groove 4 is provided with display window 5 and well 6.
In described myeloperoxidase (MPO) lateral chromatography test-strips draw-in groove 3, hs-CRP (hs-CRP) lateral chromatography test-strips draw-in groove 4, be respectively arranged with myeloperoxidase (MPO) lateral chromatography test-strips, hs-CRP (hs-CRP) lateral chromatography test-strips.
Described test card is rectangle.
The test-strips of two described test items has respectively corresponding independent well and display window; And there is a project label of corresponding test-strips in upper cover shell corresponding position.
Described myeloperoxidase (MPO) lateral chromatography test-strips draw-in groove 3, hs-CRP (hs-CRP) lateral chromatography test-strips draw-in groove 4 be arranged in parallel.Each test-strips is independent test bar; Test-strips puts in order and does not limit.
The each test item of this embodiment completes antigen-antibody reaction by corresponding lateral chromatography or gold label test strip after adding test sample, and completes interpretation and the analysis to testing result by naked eyes or instrument.
This embodiment has realized in same test card and can complete for incidence of coronary heart disease risk and disease progression simultaneously and predict two significant important symbol quality testings surveys, and the combination of these two test items can be carried out the preliminary state of an illness and risk assessment to patients with coronary heart disease.The independent test card of these two projects of comparing detects successively the utility model patent and has the features such as simple to operate, practical and convenient, quickness and high efficiency, cost.
More than show and described ultimate principle of the present utility model and principal character and advantage of the present utility model.The technician of the industry should understand; the utility model is not restricted to the described embodiments; that in above-described embodiment and instructions, describes just illustrates principle of the present utility model; do not departing under the prerequisite of the utility model spirit and scope; the utility model also has various changes and modifications, and these changes and improvements all fall within the scope of claimed the utility model.The claimed scope of the utility model is defined by appending claims and equivalent thereof.
Claims (4)
1. a coronary heart disease risk assessment combination test card, it is characterized in that, comprise test card backboard (1), upper cover (2), myeloperoxidase (MPO) lateral chromatography test-strips and draw-in groove (3) thereof, hs-CRP (hs-CRP) lateral chromatography test-strips and draw-in groove (4) thereof, display window (5) and well (6), on test card backboard (1), be provided with myeloperoxidase (MPO) lateral chromatography test-strips and draw-in groove (3) thereof, hs-CRP (hs-CRP) lateral chromatography test-strips and draw-in groove (4) thereof, upper cover (2) is arranged on test card backboard (1) top, upper cover (2) is upper corresponding to myeloperoxidase (MPO) lateral chromatography test-strips draw-in groove (3), the position of hs-CRP (hs-CRP) lateral chromatography test-strips draw-in groove (4) is provided with display window (5) and well (6).
2. a kind of coronary heart disease risk assessment combination test card according to claim 1, it is characterized in that, in described myeloperoxidase (MPO) lateral chromatography test-strips draw-in groove (3), hs-CRP (hs-CRP) lateral chromatography test-strips draw-in groove (4), be respectively arranged with myeloperoxidase (MPO) lateral chromatography test-strips, hs-CRP (hs-CRP) lateral chromatography test-strips, two test-strips are independent test bar; The test-strips of two test items is arranged in parallel; Test-strips puts in order and does not limit.
3. a kind of coronary heart disease risk assessment combination test card according to claim 1, is characterized in that, the test-strips of described two test items has respectively corresponding independent well and display window; And there is a project label of corresponding test-strips in upper cover shell corresponding position.
4. a kind of coronary heart disease risk assessment combination test card according to claim 1, is characterized in that, described test card is rectangle.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201320787802.2U CN203616315U (en) | 2013-12-05 | 2013-12-05 | Combined detecting card for coronary heart disease risk assessment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201320787802.2U CN203616315U (en) | 2013-12-05 | 2013-12-05 | Combined detecting card for coronary heart disease risk assessment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN203616315U true CN203616315U (en) | 2014-05-28 |
Family
ID=50768948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201320787802.2U Expired - Fee Related CN203616315U (en) | 2013-12-05 | 2013-12-05 | Combined detecting card for coronary heart disease risk assessment |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN203616315U (en) |
-
2013
- 2013-12-05 CN CN201320787802.2U patent/CN203616315U/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Priya et al. | Comparison of capillary whole blood versus venous plasma glucose estimations in screening for diabetes mellitus in epidemiological studies in developing countries | |
| WO2015096767A1 (en) | Full-automatic instant check meter | |
| Singh et al. | Evaluation of various methods of point-of-care testing of haemoglobin concentration in blood donors | |
| CN104407127B (en) | A kind of dry type body fluid analysis instrument and the method for analysis thereof | |
| CN106872434A (en) | A kind of portable pen type immunofluorescence chromatography detection means | |
| CN103263270A (en) | Blood-glucose meter | |
| CN108932976A (en) | A kind of non-alcohol fatty liver Noninvasive diagnosis program | |
| Gerday et al. | Urinary ferritin; a potential noninvasive way to screen NICU patients for iron deficiency | |
| CN103776914A (en) | Biomarker of male infertility in unknown aetiology and application method of biomarker | |
| Ridenour et al. | Comparison and validation of point of care lactate meters as a replacement for fetal pH measurement | |
| CN203303031U (en) | Diabetes non-invasive detecting device based on glycation end product fluorescence spectrum | |
| Latha et al. | Design and development of A microcontroller based system for the measurement of blood glucose | |
| CN203616315U (en) | Combined detecting card for coronary heart disease risk assessment | |
| CN207457241U (en) | A kind of hand-held blood analyser | |
| Zhou et al. | Real-time three-dimensional echocardiography predicts cardiotoxicity induced by postoperative chemotherapy in breast cancer patients | |
| CN203616318U (en) | Risk assessment combined detection card for acute myocardial infarction | |
| CN205958464U (en) | Domestic urine detection appearance | |
| CN203616317U (en) | Combined test card for acute myocardial infarction (AMI) diagnosis | |
| CN2739640Y (en) | Urine analytic instrument | |
| CN213957408U (en) | Blood protein analysis device | |
| CN203616313U (en) | Combined test card for heart disease | |
| CN211528219U (en) | Urine analysis device | |
| CN106018768A (en) | Multi-project biochemical examination and analysis integrated kit | |
| CN201689040U (en) | Colloidal gold-labeled detector for cardiac infarction or heart failure mark | |
| CN206531856U (en) | A kind of health controller for being applicable hyperglycaemia people |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| DD01 | Delivery of document by public notice |
Addressee: BEIJING HUICHUANGYI MEDICAL TECHNOLOGY Co.,Ltd. Document name: Notification that Application Deemed not to be Proposed |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Patent of Beijing huichuangyi Medical Technology Co.,Ltd. The person in charge Document name: payment instructions |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Patent of Beijing huichuangyi Medical Technology Co.,Ltd. The person in charge Document name: Patent termination notice |
|
| DD01 | Delivery of document by public notice | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140528 Termination date: 20211205 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |